Search
Cloxypendyl
go.drugbank.com/drugs/DB20322ExperimentalCloxypendyl is a small molecule drug. The usage of the INN stem '-pendyl' in the name indicates that Cloxypendyl is a vasodilator. Cloxypendyl has a monoisotopic molecular weight of 404.14 Da.
Bamirastine
go.drugbank.com/drugs/DB21186ExperimentalBamirastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Bamirastine is a antihistaminic. Bamirastine has a monoisotopic molecular weight of 527.29 Da.
Barmastine
go.drugbank.com/drugs/DB21253ExperimentalBarmastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.
Zanoterone
go.drugbank.com/drugs/DB21384ExperimentalZanoterone is a small molecule drug. The usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.
Ancitabine
go.drugbank.com/drugs/DB20595ExperimentalAncitabine has a monoisotopic molecular weight of 225.07 Da. … Ancitabine is a small molecule drug.
Nelistotug
go.drugbank.com/drugs/DB19334InvestigationalNelistotug is under investigation in clinical trial NCT06062420 (A Platform Study of Novel Immunotherapy Combinations as First-line Treatment in Participants With PD-L1 Positive Recurrent/metastatic Squamous
Galocitabine
go.drugbank.com/drugs/DB21373ExperimentalGalocitabine has a monoisotopic molecular weight of 439.14 Da. … Galocitabine is a small molecule drug.
Alpibectir
go.drugbank.com/drugs/DB21561InvestigationalAlpibectir has a monoisotopic molecular weight of 332.1 Da. … Alpibectir is a small molecule drug.
Ceperognastat
go.drugbank.com/drugs/DB21591InvestigationalCeperognastat has a monoisotopic molecular weight of 383.14 Da. … Ceperognastat is a small molecule drug.
Ranosidenib
go.drugbank.com/drugs/DB21727InvestigationalRanosidenib has a monoisotopic molecular weight of 453.12 Da. … Ranosidenib is a small molecule drug. Ranosidenib is under investigation in clinical trial NCT06387069 (A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia).